1. Home
  2. AMRX
  3. AMRX News

Latest Amneal Pharmaceuticals Inc. (AMRX) News on September 18, 2025

Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension

GlobeNewswire

13 days ago

Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension

Share on Social Networks: